Clinical Trials Directory

Trials / Unknown

UnknownNCT05461404

Emollient Therapy for Premature Infants in Zimbabwe

Emollient Therapy for Improved Survival and Growth of Very Low Birth Weight Infants in Zimbabwe

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
520 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
28 Days
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the efficacy of topical emollient treatments in improving neonatal growth and mortality rates.

Detailed description

For infants whose parent/caretaker provides written informed consent, the study nurse coordinator on-site will allocate infants to one of two strata (700- \<1000 g or 1000-1500 g). Participants within each stratum will be randomly assigned in a 1:1 ratio to one of two treatment groups: 1) high-linoleate SSO, or 2) standard-of-care treatment without use of topical emollients or massage.

Conditions

Interventions

TypeNameDescription
OTHERTopical Emollient TherapyApplication of high-linoleate (\>60% linoleic acid) SSO to the epidermis.

Timeline

Start date
2023-08-01
Primary completion
2025-05-31
Completion
2025-12-31
First posted
2022-07-18
Last updated
2023-04-19

Locations

1 site across 1 country: Zimbabwe

Source: ClinicalTrials.gov record NCT05461404. Inclusion in this directory is not an endorsement.